基于DFT QTAIM和对接分析,为增强抗癌功效而设计西斯丁和碳丁复合物的合理设计
Mohammed Ghazwani1, Umme Hani2
1Department of Pharmaceutics, College of Pharmacy, King Khalid University, Al Faraa, 62223, Abha, Saudi Arabia. my.ghazwani@kku.edu.sa.
Scientific reports
|January 7, 2026
概括
新的西斯-卡博复合物通过改善稳定性和药物输送,显示出增强的抗癌潜力. 这些基于的药物提供了一个有前途的策略,以提高癌症治疗的疗效和减少毒性.
科学领域:
- 计算化学是一种计算化学.
- 分子建模分子建模
- 药物发现 药物发现
背景情况:
- 西斯 (CP) 和碳 (CBP) 是重要的基于的抗癌药物.
- 由于毒性和疗效问题,CP和CBP的临床使用受到限制.
- 需要新的策略来改善基于的化疗.
研究的目的:
- 为了探索-碳- [CP-CBP] 复合物的协同作用.
- 研究[CP-CBP]复合体在乳腺癌和宫癌中的潜力.
- 提高抗癌疗效,降低基药物的毒性.
主要方法:
- 密度功能理论 (DFT) 和分子中的原子量子理论 (QTAIM) 用于结构和电子分析.
- 分子对接以预测药物向相互作用.
- 用光谱分析 (UV-Vis,IR) 来确认结构和电子变化.
主要成果:
- [CP-CBP] 复合体表现出增强的结构稳定性和热力学有利性 (ΔH < 0).
- 量子描述符表明反应性增加和药物标相互作用的改善.
- 分子对接揭示了[CP-CBP]复合体的优越结合亲和力,与单个药物相比,对芳酶和HER2等点具有更高的结合亲和力.
结论:
- [CP-CBP]复合物显示出作为改进的基化疗药物的潜力.
- 这些复合物提供了增强的生物可用性,溶解性和受控释放,降低了毒性.
- 需要进一步的体外和体内研究来验证针对癌症治疗的[CP-CBP]复合物.
相关概念视频
Structure-Activity Relationships and Drug Design
1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K


